COVID-19 Diagnostics Market Size, Share & Trends Report

COVID-19 Diagnostics Market (2024 - 2030) Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Kits, Services), By Sample Type, By Test Type, By Mode, By End Use, By Region, And Segment Forecasts

Market Segmentation

COVID-19 Diagnostics Product & Service Outlook (Revenue, USD Million, 2020 - 2030)
- Instruments
- Reagents & Kits
- Services
COVID-19 Diagnostics Sample Type Outlook (Revenue, USD Million, 2020 - 2030)
- Nasopharyngeal (NP) swabs
- Oropharyngeal (OP) swabs
- Nasal swabs
- Blood
- Others
COVID-19 Diagnostics Test Type Outlook (Revenue, USD Million, 2020 - 2030)
- Molecular (PCR) Testing
- Antigen-based Testing
- Antibody (Serology) Testing
- Others
COVID-19 Diagnostics Mode Outlook (Revenue, USD Million, 2020 - 2030)
- Point-of-Care (PoC)
- Non-Point-of-Care (Non-PoC)
COVID-19 Diagnostics End-use Outlook (Revenue, USD Million, 2020 - 2030)
- Laboratories
- Hospitals
- Diagnostic Centers and Clinics
- Others
COVID-19 Diagnostics Market: Regional Outlook (Revenue, USD Million, 2020-2030)
- North America
  - North America COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
    - Instruments
    - Reagents & Kits
    - Services
  - North America COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
    - Nasopharyngeal (NP) swabs
    - Oropharyngeal (OP) swabs
    - Nasal swabs
    - Blood
    - Others
  - North America COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
    - Molecular (PCR) Testing
    - Antigen-based Testing
    - Antibody (Serology) Testing
    - Others
  - North America COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
    - Point-of-Care (PoC)
    - Non-Point-of-Care (Non-PoC)
  - North America COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
    - Laboratories
    - Hospitals
    - Diagnostic Centers and Clinics
    - Others
  - U.S.
    - U.S. COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - U.S. COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - U.S. COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - U.S. COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - U.S. COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Canada
    - Canada COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Canada COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Canada COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Canada COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Canada COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
- Europe
  - Europe COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
    - Instruments
    - Reagents & Kits
    - Services
  - Europe COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
    - Nasopharyngeal (NP) swabs
    - Oropharyngeal (OP) swabs
    - Nasal swabs
    - Blood
    - Others
  - Europe COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
    - Molecular (PCR) Testing
    - Antigen-based Testing
    - Antibody (Serology) Testing
    - Others
  - Europe COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
    - Point-of-Care (PoC)
    - Non-Point-of-Care (Non-PoC)
  - Europe COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
    - Laboratories
    - Hospitals
    - Diagnostic Centers and Clinics
    - Others
  - UK
    - UK COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - UK COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - UK COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - UK COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - UK COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Germany
    - Germany COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Germany COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Germany COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Germany COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Germany COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - France
    - France COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - France COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - France COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - France COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - France COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Italy
    - Italy COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Italy COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Italy COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Italy COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Italy COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Spain
    - Spain COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Spain COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Spain COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Spain COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Spain COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Sweden
    - Sweden COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Sweden COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Sweden COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Sweden COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Sweden COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Norway
    - Norway COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Norway COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Norway COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Norway COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Norway COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Denmark
    - Denmark COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Denmark COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Denmark COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Denmark COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Denmark COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
- Asia Pacific
  - Asia Pacific COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
    - Instruments
    - Reagents & Kits
    - Services
  - Asia Pacific COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
    - Nasopharyngeal (NP) swabs
    - Oropharyngeal (OP) swabs
    - Nasal swabs
    - Blood
    - Others
  - Asia Pacific COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
    - Molecular (PCR) Testing
    - Antigen-based Testing
    - Antibody (Serology) Testing
    - Others
  - Asia Pacific COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
    - Point-of-Care (PoC)
    - Non-Point-of-Care (Non-PoC)
  - Asia Pacific COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
    - Laboratories
    - Hospitals
    - Diagnostic Centers and Clinics
    - Others
  - Japan
    - Japan COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Japan COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Japan COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Japan COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Japan COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - China
    - China COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - China COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - China COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - China COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - China COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - India
    - India COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - India COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - India COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - India COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - India COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Australia
    - Australia COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Australia COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Australia COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Australia COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Australia COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Thailand
    - Thailand COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Thailand COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Thailand COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Thailand COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Thailand COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - South Korea
    - South Korea COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - South Korea COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - South Korea COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - South Korea COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - South Korea COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
- Latin America
  - Latin America COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
    - Instruments
    - Reagents & Kits
    - Services
  - Latin America COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
    - Nasopharyngeal (NP) swabs
    - Oropharyngeal (OP) swabs
    - Nasal swabs
    - Blood
    - Others
  - Latin America COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
    - Molecular (PCR) Testing
    - Antigen-based Testing
    - Antibody (Serology) Testing
    - Others
  - Latin America COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
    - Point-of-Care (PoC)
    - Non-Point-of-Care (Non-PoC)
  - Latin America COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
    - Laboratories
    - Hospitals
    - Diagnostic Centers and Clinics
    - Others
  - Brazil
    - Brazil COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Brazil COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Brazil COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Brazil COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Brazil COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Mexico
    - Mexico COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Mexico COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Mexico COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Mexico COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Mexico COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Argentina
    - Argentina COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Argentina COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Argentina COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Argentina COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Argentina COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
- MEA
  - MEA COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
    - Instruments
    - Reagents & Kits
    - Services
  - MEA COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
    - Nasopharyngeal (NP) swabs
    - Oropharyngeal (OP) swabs
    - Nasal swabs
    - Blood
    - Others
  - MEA COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
    - Molecular (PCR) Testing
    - Antigen-based Testing
    - Antibody (Serology) Testing
    - Others
  - MEA COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
    - Point-of-Care (PoC)
    - Non-Point-of-Care (Non-PoC)
  - MEA COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
    - Laboratories
    - Hospitals
    - Diagnostic Centers and Clinics
    - Others
  - Saudi Arabia
    - Saudi Arabia COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Saudi Arabia COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Saudi Arabia COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Saudi Arabia COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Saudi Arabia COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - South Africa
    - South Africa COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - South Africa COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - South Africa COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - South Africa COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - South Africa COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - UAE
    - UAE COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - UAE COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - UAE COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - UAE COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - UAE COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others
  - Kuwait
    - Kuwait COVID-19 Diagnostics Market, by Product & Service (Revenue, USD Million; 2020 - 2030)
      - Instruments
      - Reagents & Kits
      - Services
    - Kuwait COVID-19 Diagnostics Market, by Sample Type (Revenue, USD Million; 2020 - 2030)
      - Nasopharyngeal (NP) swabs
      - Oropharyngeal (OP) swabs
      - Nasal swabs
      - Blood
      - Others
    - Kuwait COVID-19 Diagnostics Market, by Test Type (Revenue, USD Million; 2020 - 2030)
      - Molecular (PCR) Testing
      - Antigen-based Testing
      - Antibody (Serology) Testing
      - Others
    - Kuwait COVID-19 Diagnostics Market, by Mode (Revenue, USD Million; 2020 - 2030)
      - Point-of-Care (PoC)
      - Non-Point-of-Care (Non-PoC)
    - Kuwait COVID-19 Diagnostics Market, by End Use (Revenue, USD Million; 2020 - 2030)
      - Laboratories
      - Hospitals
      - Diagnostic Centers and Clinics
      - Others

COVID-19 Diagnostics Market Dynamics

Drivers: Increasing Product Approvals By Regulatory Agencies

The COVID-19 pandemic has spurred demand for diagnostic tests. Companies are intensifying R&D efforts to develop innovative tests and secure regulatory approvals. For example, Mammoth Biosciences received FDA Emergency Use Authorization (EUA) for its high-throughput CRISPR-based COVID-19 test in January 2022. Labcorp also received FDA approval for its nonprescription test that can detect various viruses including COVID-19 in May 2022. In addition, F. Hoffmann-La Roche AG received EUA from the FDA for its Elecsys Anti-SARS-CoV-2 antibody test in May 2020. India-based Mylab Discovery Solutions developed the first COVID-19 test kit and received approval from the Indian FDA/Central Drugs Standard Control Organization (CDSCO) in March 2020. Furthermore, strategic collaborations are underway to develop efficient COVID-19 diagnostic tests. For instance, the FDA approved EUA for the InspectIR COVID-19 Breathalyzer test in April 2022. Thermo Fisher Scientific is also developing a new COVID-19 serology test in collaboration with Mayo Clinic and WuXi Diagnostics. The increasing number of approved COVID-19 diagnostics is expected to significantly boost market growth.

Government Initiatives Toward Mass Testing

The COVID-19 pandemic has resulted in significant loss of life and other impacts. As of June 2022, WHO data shows approximately 537,591,764 confirmed cases and around 6,319,395 deaths globally. Countries like the U.S., Brazil, Russia, the UK, Spain, Italy, India, Germany, Peru, Turkey, Iran, and France have reported the most cases. Health organizations recommend mass testing as a strategy to control the disease’s spread. In response, governments are focusing on increasing testing rates. For example, Luxembourg initiated mass testing for 600,000 patients in May 2020 to prevent a second wave. The UK exceeded its target of 200,000 tests per day by the end of May 2020. Wuhan tested 11 million people in May 2020 after reporting 21 new cases. Hong Kong started voluntary mass testing in September 2020, testing about 1.78 million individuals. Despite criticism, the UK government announced plans for mass testing in September 2020, aiming to increase daily testing capacity to 500,000 by October end. The UK government also ordered 5.8 million POC testing kits in September 2020 and plans to test the entire population weekly from early 2021.

Restrains: Paradigm Shift Toward Poc Testing

Point-of-care (POC) testing provides real-time, lab-quality results at patient care sites like urgent care centers and hospitals. Amid the COVID-19 pandemic, diagnostic test developers are focusing on creating fast, user-friendly POC tests for non-laboratory settings. For example, Cepheid, a Danaher Corporation subsidiary, received FDA Emergency Use Authorization (EUA) for its POC COVID-19 test, Cepheid Xpert Xpress SARS-CoV-2, in March 2020. Similarly, Abbott Laboratories received EUA for its new molecular POC COVID-19 test that delivers results in less than 5 minutes. In April 2021, the FDA approved an amended EUA request for various COVID-19 tests, expanding POC and over-the-counter (OTC) testing options. The FDA-approved tests include Abbott BinaxNOW COVID-19 Antigen Self-Test and Quidel QuickVue At-Home OTC COVID-19 test for OTC at-home serial screening, BD Veritor System for Rapid Detection of SARS-CoV-2 for POC serial screening with a prescription, and Abbott BinaxNOW COVID-19 Ag 2 Card for POC serial screening without a prescription. Assure COVID-19 IgG/IgM Rapid Test Device received reauthorization for its use as a POC antibody test for SARS-CoV-2 testing in September 2020

What Does This Report Include?

This section will provide insights into the contents included in this COVID-19 diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

COVID-19 diagnostics market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments